Home » Stocks » EVFM

Evofem Biosciences, Inc. (EVFM)

Stock Price: $1.15 USD 0.05 (4.09%)
Updated Jun 21, 2021 12:32 PM EDT - Market open
Market Cap 168.12M
Revenue (ttm) 1.55M
Net Income (ttm) -169.31M
Shares Out 81.84M
EPS (ttm) -2.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 21
Last Price $1.15
Previous Close $1.10
Change ($) 0.05
Change (%) 4.09%
Day's Open 1.14
Day's Range 1.05 - 1.15
Day's Volume 9,686,470
52-Week Range 0.75 - 5.53

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

3 big gaining penny stocks today; are they worth it? The post These Penny Stocks Are Up Big Today, Worth It or Not?

Other stocks mentioned: APOP, JFU
4 days ago - PennyStocks

Penny stocks to watch right now after insiders bought in June. The post 5 Top Penny Stocks Insiders Decided To Buy In June 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Penny...

Other stocks mentioned: DPW, ETTX, OPGN, PRPO
6 days ago - PennyStocks

Penny stocks for 2021? Check these 3 under $3 small-caps out The post Hot Penny Stocks For 2021, 3 Under $3 You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...

Other stocks mentioned: ANY, DOGZ
1 week ago - PennyStocks

Which penny stocks are on your June watchlist? The post Penny Stocks to Watch This Week?

Other stocks mentioned: BRQS, NEXT
2 weeks ago - PennyStocks

SAN DIEGO, June 1, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Saundra Pelletier, Chief Executive Officer, will present at the Jefferies Virtual Healthcare Confere...

2 weeks ago - PRNewsWire

With biotech penny stocks back in focus, which small-caps are you watching? The post Hot Biotech Penny Stocks To Buy?

Other stocks mentioned: ITRM, TTOO
3 weeks ago - PennyStocks

SAN DIEGO, May 25, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that its CEO Saundra Pelletier will present at the 2021 LD Micro Invitational XI on Tuesday, June 8, 2021...

3 weeks ago - PRNewsWire

SAN DIEGO, May 21, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the closing of its previously announced underwritten public offering of 50 million shares of its common st...

1 month ago - PRNewsWire

EVFM stock is plunging after the women's health company announced and priced a stock and warrant offering. The post EVFM Stock: One Big Reason Why Evofem Biosciences Is Plunging Today appeared first on ...

1 month ago - InvestorPlace

Evofem Biosciences Inc (NASDAQ: EVFM) has priced its previously announced underwritten public offering of 50 million shares and accompanying short-term warrants to purchase up to an aggregate of 50 mill...

1 month ago - Benzinga

SAN DIEGO, May 17, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the pricing of its previously announced underwritten public offering of 50,000,000 shares of its common st...

1 month ago - PRNewsWire

SAN DIEGO, May 17, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that it intends to offer and sell in an underwritten public offering, subject to market and other conditio...

1 month ago - PRNewsWire

SAN DIEGO, May 17, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that new research on its investigational drug EVO100 for the prevention of chlamydia and gonorrhea in wom...

1 month ago - PRNewsWire

The FDA has granted Fast Track designation to Fulcrum Therapeutics Inc's (NASDAQ: FULC) losmapimod for the potential treatment of facioscapulohumeral muscular dystrophy (FSHD). Fulcrum is on track to re...

Other stocks mentioned: FULC
1 month ago - Benzinga

Biotech penny stocks are heating up right now; here's 4 to watch The post Best Biotech Penny Stocks to Buy Under $5? 4 To Check Out in May appeared first on Penny Stocks to Buy, Picks, News and Informat...

Other stocks mentioned: NERV, NOVN, OBLN
1 month ago - PennyStocks

SAN DIEGO, May 12, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for EVO100 for the pr...

1 month ago - PRNewsWire

Looking for the best penny stocks in May 2021? Check these 5 out The post 5 Hot Penny Stocks To Buy?

Other stocks mentioned: APOP, ATOS, FFNTF, XXII
1 month ago - PennyStocks

SAN DIEGO, May 6, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), today reported financial results for the three-month period ended March 31, 2021. First quart...

1 month ago - PRNewsWire

SAN DIEGO, April 28, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that two new data sets from its Phase 3 AMPOWER trial evaluating Phexxi® (lactic acid, citric acid, pot...

1 month ago - PRNewsWire

SAN DIEGO, April 22, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to discuss the Company's financial results and business highlights for the firs...

1 month ago - PRNewsWire

SAN DIEGO, April 21, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced the company will deliver the keynote address and present two poster presentations on Phexxi® (lactic ac...

2 months ago - PRNewsWire

SAN DIEGO, March 29, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the closing of its previously announced underwritten public offering of 17,142,857 shares of its common ...

2 months ago - PRNewsWire

Cellect Biotechnology Ltd. (NASDAQ: APOP), Immutep Limited (NASDAQ: IMMP), F-star Therapeutics, Inc. (NASDAQ: FSTX), ProQR Therapeutics N.V.

Other stocks mentioned: APOP, FSTX, IMMP, PRQR
2 months ago - Benzinga

SAN DIEGO, March 24, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a price to th...

2 months ago - PRNewsWire

SAN DIEGO, March 24, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that it intends to offer and sell, subject to market and other conditions, $30 million of shares of its ...

2 months ago - PRNewsWire

SAN DIEGO, March 17, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that "Get Phexxi," its national direct-to-consumer (DTC) campaign aimed at broadening awareness of its ...

3 months ago - PRNewsWire

Insiders sell for many reasons, but they only buy for one. To make money.

Other stocks mentioned: APRN, CWEN, HUM, POOL, WEN, WMT
3 months ago - InvestorPlace

SAN DIEGO, March 16, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced publication of the pivotal manuscript from the AMPREVENCE clinical trial in the highly respected Americ...

3 months ago - PRNewsWire

The company's performance during the fourth quarter was short of expectations.

3 months ago - The Motley Fool

Shares of Evofem Biosciences (NASDAQ:EVFM) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 85.19% over the past year to ($0.50), w...

3 months ago - Benzinga

SAN DIEGO, March 4, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the three- and twelve-month periods e...

3 months ago - PRNewsWire

These penny stocks are companies that have a crucial year ahead in terms of industry turnaround or company specific product development. The post 7 Penny Stocks In a Make-or-Break Year appeared first on...

Other stocks mentioned: BORR, IBIO, KSHB, OILFF, SB, TMBR
3 months ago - InvestorPlace

SAN DIEGO, Feb. 18, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) will hold a webcast and conference call to discuss the Company's financial results and business highlights for the fourth...

4 months ago - PRNewsWire

Initial prescription data for Phexxi looks very positive. Both the number of new users and estimated revenues to date have exceeded my initial modeling.

5 months ago - Seeking Alpha

SAN DIEGO, Dec. 22, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it has entered into an agreement with the U.S. Centers for Medicare and Medicaid Services (CMS) to parti...

5 months ago - PRNewsWire

SAN DIEGO, Dec. 3, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that the U.S. Department of Veterans Affairs (VA) has awarded the Company a contract for the purchase of ...

6 months ago - PRNewsWire

SAN DIEGO, Nov. 20, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, taking place virtual...

7 months ago - PRNewsWire

EVFM has dipped back into the low $2s due to the daunting task of launching a product without a major company's assistance. I review recent developments and then run my estimates of revenue ramp vs. cas...

7 months ago - Seeking Alpha

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q3 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q3 2020 Results - Quick Version Earnings Call Transcript

7 months ago - Seeking Alpha

SAN DIEGO, Nov. 9, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), today reported financial results for the three- and nine- month periods ended September 30, ...

7 months ago - PRNewsWire

Evofem vaginal pH modulation technology is a differentiated product being used to target unmet needs in women's health.

8 months ago - Seeking Alpha

SAN DIEGO, Oct. 20, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced enrollment of the first patient in its pivotal Phase 3 clinical trial evaluating the safety and efficacy...

8 months ago - PRNewsWire

SAN DIEGO, Sept. 16, 2020 /PRNewswire/ -- Evofem Biosciences, Inc.

9 months ago - PRNewsWire

Investors need to pay close attention to Evofem Biosciences (EVFM) stock based on the movements in the options market lately.

9 months ago - Zacks Investment Research

Evofem: Why I Bought Friday's Massive Spike Down

9 months ago - Seeking Alpha

The company's CEO made a noteworthy move.

9 months ago - The Motley Fool

SAN DIEGO, Aug. 21, 2020 /PRNewswire/ -- Evofem Biosciences, Inc.

9 months ago - PRNewsWire

Investors need to pay close attention to Evofem Biosciences (EVFM) stock based on the movements in the options market lately.

10 months ago - Zacks Investment Research

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q2 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

About EVFM

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. It has a collaboration agreement with National Community Oncology Dispensing Association... [Read more...]

Industry
Biotechnology
CEO
Saundra Pelletier
Employees
147
Stock Exchange
NASDAQ
Ticker Symbol
EVFM
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for EVFM stock is "Buy." The 12-month stock price forecast is 6.40, which is an increase of 458.95% from the latest price.

Price Target
$6.40
(458.95% upside)
Analyst Consensus: Buy